These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38919490)

  • 1. Risk of intracranial meningioma in patients with acromegaly: a systematic review.
    Guo AX; Job A; Pacione D; Agrawal N
    Front Endocrinol (Lausanne); 2024; 15():1407615. PubMed ID: 38919490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unusual pituitary adenoma coexistent with bilateral meningiomas: case report.
    Kumaria A; Scott IS; Robertson IJ
    Br J Neurosurg; 2019 Oct; 33(5):579-580. PubMed ID: 28961022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Silent' somatotropinoma.
    Pawlikowski M; Kuta J; Fuss-Chmielewska J; Winczyk K
    Endokrynol Pol; 2012; 63(2):88-91. PubMed ID: 22538745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
    Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
    J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case.
    Curto L; Squadrito S; Almoto B; Longo M; Granata F; Salpietro F; Torre ML; Marini F; Trimarchi F; Cannavo S
    Pituitary; 2007; 10(3):299-305. PubMed ID: 17334927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acromegaly with normal growth hormone levels: response to Sandostatin-LAR treatment.
    Shimon I; Nass D; Hadani M
    Pituitary; 2000 May; 2(4):289-94. PubMed ID: 11081151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Incidence of Intracranial Meningiomas in Patients With Acromegaly.
    Engelhardt J; Nunes ML; Pouchieu C; Ferrière A; San-Galli F; Gimbert E; Vignes JR; Laurent F; Berge J; Baldi I; Tabarin A; Loiseau H
    Neurosurgery; 2020 Sep; 87(4):639-646. PubMed ID: 31625569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
    Schwyzer L; Starke RM; Jane JA; Oldfield EH
    J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Not Available].
    Mosbah H; Brue T; Chanson P
    Ann Endocrinol (Paris); 2019 Sep; 80 Suppl 1():S10-S18. PubMed ID: 31606057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-related differences in growth hormone-releasing pituitary adenomas. A clinicopathological study.
    Schaller B
    Pituitary; 2002; 5(4):247-53. PubMed ID: 14558673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
    Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
    Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acromegaly and it's cardiovascular implications].
    Cadena-Obando DA; Remba-Shapiro I; Abreu-Rosario CG; Mercado M
    Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):73-80. PubMed ID: 33667046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collision tumors composed of meningioma and growth hormone-secreting pituitary adenoma in the sellar region: Case reports and a literature review.
    Zhao Y; Zhang H; Lian W; Xing B; Feng M; Liu X; Wang R
    Medicine (Baltimore); 2017 Dec; 96(50):e9139. PubMed ID: 29390316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
    Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
    Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.
    Cheng S; Al-Agha R; Araujo PB; Serri O; L Asa S; Ezzat S
    PLoS One; 2013; 8(9):e73543. PubMed ID: 24039977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acromegaly--do we already know everything about treatment of the somatotroph pituitary adenomas?].
    Zieliński G; Podgórski JK
    Przegl Lek; 2002; 59(7):540-7. PubMed ID: 12516247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of petrosal sinus sampling: coexisting acromegaly, empty sella and meningioma.
    Yarman S; Minareci O
    Neuroradiology; 2004 Dec; 46(12):1027-30. PubMed ID: 15580492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone secreting pituitary carcinomas: Case report and review of literature.
    Vekaria S; Chen F; Zan E; William C; Sen C; Lebowitz R; Zagzag D; Warren FA; Brandler TC; Agrawal N
    Growth Horm IGF Res; 2021; 60-61():101430. PubMed ID: 34607164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
    Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
    J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.